Skip to main content

Biomarker identification in blood for improved cancer diagnosis and response monitoring to immune-checkpoint blockade

24 Sep 2024
Immune Biomarkers
  • Is it ready for prime time?  Do we have sufficient data?
  • Is there consensus around a standardized assay?
  • Access and reimbursement issues
Industry Expert
Connie Tat, Senior Medical Science Director - Genentech